US · Healthcare

Marvel Biosciences Corp. (MBCOF)

Biotechnology

Marvel Biosciences Corp. (MBCOF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MBCOF

P/E ratio

25.00

Marvel Biosciences Corp. (MBCOF) — FAQ

What is MBCOF's P/E ratio?

The price-to-earnings (P/E) ratio for Marvel Biosciences Corp. (MBCOF) is 25.00 (data as of 2026-05-23).

Does Marvel Biosciences Corp. pay a dividend?

Dividend yield is not available in the current snapshot for Marvel Biosciences Corp. (MBCOF). Check the MyAverix Finance app for the latest dividend data.

What sector is Marvel Biosciences Corp. in?

Marvel Biosciences Corp. (MBCOF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MBCOF listed on?

MBCOF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)